Global EditionASIA 中文雙語Fran?ais
    World
    Home / World / Europe

    More countries pause vaccine roll-out for fear of potential clot risks

    By JULIAN SHEA in London | China Daily Global | Updated: 2021-03-17 09:30
    Share
    Share - WeChat
    Vials labelled with partially torn sticker "AstraZeneca COVID-19 Coronavirus Vaccine" are seen in front of a displayed EU flag in this illustration taken March 15, 2021. [Photo/Agencies]

    Officials from the United Nations and European Union are to hold talks as the temporary suspension of deployment of the AstraZeneca novel coronavirus vaccine continues to spread across the EU, because of fears that it may be connected to cases of blood clotting.

    Its suspension, said Tedros Adhanom Ghebreyesus, Director General of the World Health Organization, or WHO, "does not necessarily mean these events are linked to vaccination, but it's routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place".

    At the same time as EU countries are increasingly expressing doubts about the vaccine made by the Anglo-Swedish pharmaceutical company, European Commission President Ursula von der Leyen has announced a deal for what she called the "accelerated delivery" of 10 million doses of the vaccine developed by BioNTech and Pfizer, for the second quarter of the year.

    "This will bring the total deliveries of this vaccine to 200 million doses for that quarter," she tweeted. "It will give (EU) Member States room to manoeuvre and possibly fill gaps in deliveries."

    Germany, France, Portugal and Spain have become the latest countries to join a growing list of countries that have called a temporary halt to use of the vaccine, despite reassurances from the European Medicines Agency, or EMA, that there is no link between the vaccine and a small number of cases of people who developed blood clots after receiving it.

    Germany's Health Minister Jens Spahn said the "precautionary" measure was taken after consultation with national health regulator, the Paul Ehrlich Institute (PEI), adding that "the decision is a professional, not political one" and that any further decision on its use would be made based on new information coming from the EMA.

    "After new reports of thrombroses of the cerebral veins in connection with the vaccination in Germany and Europe, the PEI considers further investigations to be necessary," said a statement from the health ministry. "The most important thing for confidence is transparency," Spahn added.

    French President Emmanuel Macron also announced a temporary halt to its use on Monday. "The decision that was taken, in accordance with our European policy, is to suspend as a precaution the vaccination with AstraZeneca, hoping to resume it as soon as possible if the opinion is favorable," he explained. Macron made the comments at a Franco-Spanish summit, which took place as Spain too stopped using the vaccine for at least a fortnight.

    The WHO said on Monday that its Global Advisory Committee on Vaccine Safety would meet on Tuesday, and has been in close contact with the EMA, which has in turn said it will make an announcement about the AstraZeneca vaccine on Thursday, which it hopes will bring the matter to a conclusion.

    "EMA currently remains of the view that the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalization and death, outweigh the risks of side effects," the organization said in a statement.

    Better news for AstraZeneca has come from Australia, where the country's chief medical officer, Paul Kelly, says there is no link between the vaccine and blood clots.

    However, the only vaccine manufacturer in the country, CSL, has said it is in talks with the Australian government about producing alternatives to the AstraZeneca jab.

    "While CSL remains open to discussions about manufacture of alternative COVID-19 vaccines, our resources are fully committed to the manufacture of the AstraZeneca vaccine," the company's chief scientific officer, Andrew Nash, told The Guardian.

    Most Viewed in 24 Hours
    Top
    BACK TO THE TOP
    English
    Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
    License for publishing multimedia online 0108263

    Registration Number: 130349
    FOLLOW US
    亚洲无码在线播放| 欧美日韩亚洲中文字幕一区二区三区 | 日韩精品一区二区三区中文| 西西午夜无码大胆啪啪国模| 亚洲伊人久久综合中文成人网 | 狠狠躁天天躁无码中文字幕图| 欧美精品丝袜久久久中文字幕| 乱人伦中文无码视频在线观看| 国产精品无码久久综合| 亚洲综合无码AV一区二区| 久久最近最新中文字幕大全| 免费A级毛片无码无遮挡 | 中文在线中文A| 成在线人AV免费无码高潮喷水| 亚洲AV无码国产精品麻豆天美| 中文字幕精品无码一区二区 | 精品中文高清欧美| 亚洲AV永久无码天堂影院| 亚洲AV人无码激艳猛片| 在线观看片免费人成视频无码| 中文字幕日韩一区二区三区不卡| 影院无码人妻精品一区二区 | 人妻无码αv中文字幕久久| 久久av高潮av无码av喷吹| 久久精品亚洲中文字幕无码麻豆| 亚洲精品午夜无码电影网| 久久精品亚洲AV久久久无码| 无码任你躁久久久久久老妇App| 最近的中文字幕大全免费8| 亚洲精品中文字幕乱码三区| 中文字幕一区二区人妻性色| 亚洲综合最新无码专区| 亚洲?V无码乱码国产精品 | 少妇中文无码高清| 欧美日韩v中文字幕| 亚洲韩国—中文字幕| 最近中文字幕精彩视频| 最近2019中文字幕电影1| 亚洲精品一级无码中文字幕 | 一本色道无码道DVD在线观看 | 国产在线无码不卡影视影院|